Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$52.91
-2.01-3.66%
al cierre: -
$53.75
0.841.59%
After hour: 7:26 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
uniQure NV ha un obiettivo di prezzo di consenso pari a $61.5, stabilito in base alle ultime valutazioni degli analisti di 18. Le ultime 3 valutazioni degli analisti sono state rilasciate da HC Wainwright & Co., Wells Fargo y Goldman Sachs il octubre 6, 2025, octubre 2, 2025 y septiembre 25, 2025. Con un obiettivo di prezzo medio di $82 tra le HC Wainwright & Co., Wells Fargo y Goldman Sachs, c'è un implicito 52.56% upside per uniQure NV da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
HC Wainwright & Co.
Wells Fargo
Goldman Sachs
Mizuho
Guggenheim
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para uniQure
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/06/2025 | 104.65% | HC Wainwright & Co. | $70 → $110 | Maintains | Buy | |||
10/02/2025 | 48.84% | Wells Fargo | $65 → $80 | Maintains | Overweight | |||
09/25/2025 | 4.19% | Goldman Sachs | $13 → $56 | Maintains | Neutral | |||
09/25/2025 | 11.63% | Mizuho | $30 → $60 | Maintains | Outperform | |||
09/25/2025 | 20.93% | Wells Fargo | $30 → $65 | Maintains | Overweight | |||
09/25/2025 | 76.74% | Guggenheim | $28 → $95 | Maintains | Buy | |||
09/25/2025 | 48.84% | Cantor Fitzgerald | $47 → $80 | Maintains | Overweight | |||
09/25/2025 | 41.4% | Chardan Capital | $35 → $76 | Maintains | Buy | |||
09/24/2025 | 20.93% | Stifel | $30 → $65 | Maintains | Buy | |||
09/24/2025 | 26.51% | Leerink Partners | $48 → $68 | Maintains | Outperform | |||
09/24/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
09/08/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
09/08/2025 | -34.88% | Chardan Capital | $35 → $35 | Maintains | Buy | |||
09/05/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
08/29/2025 | -34.88% | Chardan Capital | $35 → $35 | Maintains | Buy | |||
07/29/2025 | -34.88% | Chardan Capital | $38 → $35 | Maintains | Buy | |||
05/30/2025 | -29.3% | Chardan Capital | $38 → $38 | Maintains | Buy | |||
05/29/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
05/12/2025 | -47.91% | Guggenheim | $28 → $28 | Reiterates | Buy → Buy | |||
05/12/2025 | -29.3% | Chardan Capital | $38 → $38 | Maintains | Buy | |||
05/06/2025 | -29.3% | Chardan Capital | $38 → $38 | Maintains | Buy | |||
04/21/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
04/01/2025 | -29.3% | Chardan Capital | $27 → $38 | Maintains | Buy | |||
03/04/2025 | 30.23% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | |||
02/28/2025 | -44.19% | Wells Fargo | $35 → $30 | Maintains | Equal-Weight | |||
01/27/2025 | 30.23% | HC Wainwright & Co. | $25 → $70 | Maintains | Buy | |||
01/21/2025 | -55.35% | RBC Capital | $24 → $24 | Reiterates | Outperform → Outperform | |||
12/19/2024 | -62.79% | Mizuho | $7 → $20 | Maintains | Neutral | |||
12/16/2024 | -40.47% | Stifel | $12 → $32 | Maintains | Buy | |||
12/12/2024 | -62.79% | Goldman Sachs | $9 → $20 | Maintains | Neutral | |||
12/11/2024 | -18.14% | Leerink Partners | — | $26 → $44 | Maintains | Outperform | ||
12/11/2024 | — | Guggenheim | — | Reiterates | Buy → Buy | |||
12/11/2024 | -62.79% | RBC Capital | $14 → $20 | Maintains | Outperform | |||
12/10/2024 | -53.49% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | |||
12/10/2024 | -3.26% | Raymond James | $20 → $52 | Upgrade | Outperform → Strong Buy | |||
12/10/2024 | 7.91% | Cantor Fitzgerald | $28 → $58 | Maintains | Overweight | |||
11/06/2024 | -53.49% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | |||
11/06/2024 | -83.26% | Goldman Sachs | $10 → $9 | Maintains | Neutral | |||
11/06/2024 | -73.95% | RBC Capital | $16 → $14 | Maintains | Outperform | |||
11/06/2024 | -47.91% | Cantor Fitzgerald | $28 → $28 | Reiterates | Overweight → Overweight | |||
10/10/2024 | -62.79% | Raymond James | → $20 | Reinstates | → Outperform | |||
09/20/2024 | -47.91% | Cantor Fitzgerald | $28 → $28 | Reiterates | Overweight → Overweight | |||
08/20/2024 | -53.49% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | |||
08/02/2024 | -81.4% | Goldman Sachs | $6 → $10 | Maintains | Neutral | |||
07/16/2024 | -55.35% | Cantor Fitzgerald | $24 → $24 | Reiterates | Overweight → Overweight | |||
07/09/2024 | -53.49% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | |||
05/08/2024 | -53.49% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | |||
05/08/2024 | -88.84% | Mizuho | $7 → $6 | Maintains | Neutral | |||
03/04/2024 | -86.98% | Mizuho | $10 → $7 | Maintains | Neutral | |||
03/01/2024 | -53.49% | HC Wainwright & Co. | $30 → $25 | Maintains | Buy | |||
02/29/2024 | -85.12% | Goldman Sachs | $63 → $8 | Downgrade | Buy → Neutral | |||
01/19/2024 | -44.19% | HC Wainwright & Co. | $30 → $30 | Reiterates | Buy → Buy | |||
01/16/2024 | -47.91% | RBC Capital | $28 → $28 | Reiterates | Outperform → Outperform | |||
12/20/2023 | -60.93% | Cantor Fitzgerald | $21 → $21 | Reiterates | Overweight → Overweight | |||
12/19/2023 | -81.4% | Mizuho | → $10 | Downgrade | Buy → Neutral | |||
11/08/2023 | 17.21% | Goldman Sachs | $56 → $63 | Maintains | Buy | |||
08/02/2023 | -44.19% | HC Wainwright & Co. | $90 → $30 | Maintains | Buy | |||
08/02/2023 | -21.86% | RBC Capital | $47 → $42 | Maintains | Outperform | |||
08/02/2023 | -6.98% | Raymond James | $56 → $50 | Maintains | Outperform | |||
06/22/2023 | -49.77% | Chardan Capital | $45 → $27 | Maintains | Buy | |||
06/21/2023 | 67.44% | HC Wainwright & Co. | → $90 | Reiterates | Buy → Buy | |||
05/19/2023 | -21.86% | UBS | $45 → $42 | Maintains | Buy | |||
05/16/2023 | -16.28% | Chardan Capital | $56 → $45 | Maintains | Buy | |||
05/16/2023 | 4.19% | Raymond James | $58 → $56 | Maintains | Outperform | |||
05/11/2023 | 2.33% | Truist Securities | $65 → $55 | Maintains | Buy | |||
05/10/2023 | -1.4% | RBC Capital | → $53 | Reiterates | → Outperform | |||
03/07/2023 | 67.44% | HC Wainwright & Co. | → $90 | Reiterates | → Buy | |||
02/28/2023 | -1.4% | Guggenheim | → $53 | Reiterates | → Buy | |||
02/28/2023 | 2.33% | Credit Suisse | $51 → $55 | Maintains | Outperform | |||
02/28/2023 | 11.63% | Chardan Capital | → $60 | Reiterates | → Buy | |||
11/23/2022 | -21.86% | UBS | $40 → $42 | Maintains | Buy | |||
11/23/2022 | 6.05% | Goldman Sachs | $47 → $57 | Maintains | Buy | |||
11/03/2022 | -10.7% | Goldman Sachs | $54 → $48 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de uniQure (QURE)?
El último precio objetivo de uniQure (NASDAQ:QURE) fue comunicado por HC Wainwright & Co. el octubre 6, 2025. La firma de analistas fijó un precio objetivo para $110.00 que espera QURE a rise dentro de 12 meses (un posible 104.65% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre uniQure (QURE)?
La última calificación de analistas para uniQure (NASDAQ:QURE) fue proporcionada por HC Wainwright & Co., y uniQure mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de uniQure (QURE)?
La última revisión al alza de uniQure NV se produjo en diciembre 10, 2024, cuando Raymond James elevó su precio objetivo a $52. Raymond James anteriormente tenía an outperform para uniQure NV.
¿Cuándo fue la última revisión a la baja de uniQure (QURE)?
La última revisión a la baja de uniQure NV se produjo en febrero 29, 2024, cuando Goldman Sachs cambió su precio objetivo de $63 a $8 para uniQure NV.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para uniQure (QURE)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de uniQure, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de uniQure se registró el octubre 6, 2025, por lo que la próxima calificación estará disponible en torno al octubre 6, 2026.
¿Es correcta la calificación de los analistas sobre uniQure (QURE)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de uniQure (QURE) fue un mantuvo con un precio objetivo de $70.00 a $110.00. El precio actual al que cotiza uniQure (QURE) es de $53.75, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.